Log In
BCIQ
Print this Print this
 

NVR 3-778, NVR-1221

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionOral small molecule inhibitor of the HBV core or capsid protein
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat chronic HBV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/04/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today